Clinical Trial

A Study of Barzolvolimab in Patients With Prurigo Nodularis

Name: A Study of Barzolvolimab in Patients With Prurigo Nodularis — clinical trial record (NCT06366750)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Active, Not Recruiting Phase 2

View on ClinicalTrials.gov →

Summary

The purpose of this study is to assess the efficacy and safety of barzolvolimab in adults with prurigo nodularis.

Protocol Amendment History 1 change

notable Primary completion moved earlier: 2026-06 -> 2026-03-17 2026-08-05

Trial Details

NCT Number	NCT06366750
Lead Sponsor	Celldex Therapeutics
Conditions	Prurigo Nodularis
Enrollment	140 participants
Start Date	2024-04-12
Primary Completion	2026-03-17 (estimated)
Study Completion	2027-03 (estimated)
Updated on ClinicalTrials.gov	2026-08-04